The effect of the TIM program (Transfer ICU Medication reconciliation) on medication transfer errors in two Dutch intensive care units: design of a prospective 8-month observational study with a before and after period

被引:10
作者
Bosma, Bertha Elizabeth [1 ,2 ,3 ]
Meuwese, Edme [3 ]
Tan, Siok Swan [4 ]
van Bommel, Jasper [5 ]
Melief, Piet Herman Gerard Jan [6 ]
Hunfeld, Nicole Geertruida Maria [5 ]
van den Bemt, Patricia Maria Lucia Adriana [3 ]
机构
[1] Haga Teaching Hosp, Dept Hosp Pharm, Els Borst Eilerspl 275, NL-2545 CH The Hague, Netherlands
[2] AHZ, Charlotte Jacobslaan 70, NL-2545 AB The Hague, Netherlands
[3] Erasmus Univ, Med Ctr, Dept Hosp Pharm, POB 2040, NL-3000 CA Rotterdam, Netherlands
[4] Erasmus Univ, Inst Med Technol Assessment, POB 1738, NL-3000 DR Rotterdam, Netherlands
[5] Erasmus Univ, Med Ctr, Intens Care Unit, POB 2040, NL-3000 CA Rotterdam, Netherlands
[6] Haga Teaching Hosp, Intens Care Unit, Leyweg 275, NL-2545 CH The Hague, Netherlands
关键词
Medication reconciliation; Medication error; Intensive care unit; Medication transfer; Clinical pharmacist; Adverse drug event; ADVERSE DRUG EVENTS; THERAPY AFTER-DISCHARGE; INAPPROPRIATE CONTINUATION; HOSPITALIZED-PATIENTS; COSTS; INTERVENTIONS; REDUCE;
D O I
10.1186/s12913-017-2065-y
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The transfer of patients to and from the Intensive Care Unit (ICU) is prone to medication errors. The aim of the present study is to determine whether the number of medication errors at ICU admission and discharge and the associated potential harm and costs are reduced by using the Transfer ICU and Medication reconciliation (TIM) program. Methods: This prospective 8-month observational study with a pre-and post-design will assess the effects of the TIM program compared with usual care in two Dutch hospitals. Patients will be included if they are using at least one drug before hospital admission and will stay in the ICU for at least 24 h. They are excluded if they are transferred to another hospital, admitted and discharged in the same weekend or unable to communicate in Dutch or English. In the TIM program, a clinical pharmacist reconciles patient's medication history within 24 h after ICU admission, resulting in a "best possible" medication history and presents it to the ICU doctor. At ICU discharge the clinical pharmacist reconciles the prescribed ICU medication and the medication history with the ICU doctor, resulting in an ICU discharge medication list with medication prescription recommendations for the general ward doctor. Primary outcome measures are the proportions of patients with one or more medication transfer errors 24 h after ICU admission and 24 h after ICU discharge. Secondary outcome measures are the proportion of patients with potential adverse drug events, the severity of potential adverse drug events and the associated costs. For the primary outcome relative risks and 95% confidence intervals will be calculated. Discussion: Strengths of this study are the tailor-made design of the TIM program and two participating hospitals. This study also has some limitations: A potential selection bias since this program is not performed during the weekends, collecting of potential rather than actual adverse drug events and finally a relatively short study period. Nevertheless, the findings of this study will provide valuable information on a crucial safety intervention in the ICU.
引用
收藏
页数:10
相关论文
共 26 条
[1]   The costs of adverse drug events in hospitalized patients [J].
Bates, DW ;
Spell, N ;
Cullen, DJ ;
Burdick, E ;
Laird, N ;
Petersen, LA ;
Small, SD ;
Sweitzer, BJ ;
Leape, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :307-311
[2]   Association of ICU or Hospital Admission With Unintentional Discontinuation of Medications for Chronic Diseases [J].
Bell, Chaim M. ;
Brener, Stacey S. ;
Gunraj, Nadia ;
Huo, Cindy ;
Bierman, Arlene S. ;
Scales, Damon C. ;
Bajcar, Jana ;
Zwarenstein, Merrick ;
Urbach, David R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (08) :840-847
[3]  
Benkirane Raja R, 2009, J Patient Saf, V5, P16, DOI 10.1097/PTS.0b013e3181990d51
[4]   Preventable adverse drug events in hospitalized patients: A comparative study of intensive care and general care units [J].
Cullen, DJ ;
Sweitzer, BJ ;
Bates, DW ;
Burdick, E ;
Edmondson, A ;
Leape, LL .
CRITICAL CARE MEDICINE, 1997, 25 (08) :1289-1297
[5]   Incidence and Costs of Adverse Drug Reactions in a Tertiary Care Pediatric Intensive Care Unit [J].
Du, Wei ;
Lehr, Victoria Tutag ;
Caverly, Mary ;
Kelm, Lauren ;
Reeves, Jaxk ;
Lieh-Lai, Mary .
JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (05) :567-573
[6]   Medication issues experienced by patients and carers after discharge from the intensive care unit [J].
Eijsbroek, Heleen ;
Howell, David C. J. ;
Smith, Felicity ;
Shulman, Rob .
JOURNAL OF CRITICAL CARE, 2013, 28 (01) :46-50
[7]   Cost-outcome description of clinical pharmacist interventions in a university teaching hospital [J].
Gallagher, James ;
Byrne, Stephen ;
Woods, Noel ;
Lynch, Deirdre ;
McCarthy, Suzanne .
BMC HEALTH SERVICES RESEARCH, 2014, 14
[8]   Overview of medical errors and adverse events [J].
Garrouste-Orgeas, Maite ;
Philippart, Francois ;
Bruel, Cedric ;
Max, Adeline ;
Lau, Nicolas ;
Misset, B. .
ANNALS OF INTENSIVE CARE, 2012, 2 :1-9
[9]   Stress Ulcer Prophylaxis: Reducing Non-Indicated Prescribing After Hospital Discharge [J].
Hatch, Jacob B. ;
Schulz, Lucas ;
Fish, Jeffrey T. .
ANNALS OF PHARMACOTHERAPY, 2010, 44 (10) :1565-1571
[10]   The effect of the COACH program (Continuity Of Appropriate pharmacotherapy, patient Counselling and information transfer in Healthcare) on readmission rates in a multicultural population of internal medicine patients [J].
Karapinar-Carkit, Fatma ;
Borgsteede, Sander D. ;
Zoer, Jan ;
Siegert, Carl ;
van Tulder, Maurits ;
Egberts, Antoine C. G. ;
van den Bemt, Patricia M. L. A. .
BMC HEALTH SERVICES RESEARCH, 2010, 10